<p>Biofilms, as intricate and resilient microbial communities, pose a formidable barrier to conventional antimicrobial therapies and experimental investigations due to their complex architecture and adaptive resistance mechanisms. In response to these challenges, computational methodologies have emerged as transformative tools in biofilm research, offering unparalleled insights into their formation, behavior, and interactions with therapeutic agents. This article highlights the pivotal role of advanced computational approaches, including molecular dynamics simulations, protein-ligand docking, quantitative structure-activity relationship (QSAR) modeling, and machine learning in decoding the multifaceted nature of biofilms. These in silico strategies not only complement traditional wet-lab techniques but also enable high-throughput screening, predictive modeling, and rational drug design. By bridging the gap between computational predictions and experimental validation, researchers can accelerate the development of innovative, targeted interventions against biofilm-associated infections. These advancements hold significant potential for application across multiple sectors, particularly the pharmaceutical, nutraceutical, and biomedical industries, by facilitating the design of precision antibacterial therapies and novel biofilm-disrupting agents. Collectively, this integration marks a paradigm shift in the study and management of biofilms, opening new avenues for industrial and clinical innovation.</p>